Sometimes resilience is refusing to make medical decisions while you are emotionally cornered
To rationally design more effective treatments for obesity, it is important to understand the mechanisms by which existing treatments work in humans
Start Lttl, Stay Steady
Among the most promising non-incretin receptor targets are amylin (Amy) receptors (AMYRs), supported by data from phase I and phase II clinical trials showing efficacy of the long-acting amylin and calcitonin receptor agonist, cagrilinitide (Cagri), both as monotherapy 2,3 and in combination with the selective GLP-1R agonist, semaglutide 4,5
The specific medication, formulation, and dosing strategy are determined by a licensed medical provider based on an individuals medical history, treatment goals, and approved indications
Used together or in combination, these apps address the things that actually determine long-term success on GLP-1 therapy: consistency, nutrition quality, strength maintenance, and mindset